Latest Breaking News On - Pfizer study - Page 1 : comparemela.com

The Pfizer COVID-19 vaccine remains 90% effective at reducing a person's risk of hospitalization from the virus six months after it is administered, a new study has found. This is true even in the face of the delta variant as well as if the person has not received a booster shot.

United statesSaray tartofSimone wildesKaiser permanenteUs centers for diseaseDrug administrationDisease controlKaiser permanente southern california departmentCdc guidanceCovid 19 hospitalizationCovid 19 vaccineCovid 19 vaccine effectivenessCovid 19 vaccine studyPfizer covid 19 vaccinePfizer covid 19 vaccine effectivenessPfizer study